Odyssey Health (ODYY) Share-based Compensation (2019 - 2025)
Odyssey Health's quarterly Share-based Compensation came in at $108399.0 in Q2 2025, down 89.61% year-on-year from $1.0 million in Q2 2024, and up 110.39% quarter-over-quarter from -$1.0 million in Q3 2024.
Odyssey Health has reported Share-based Compensation for 7 years, with the latest figure at $108399.0 in Q2 2025.
- For the quarter ending Q2 2025, Share-based Compensation fell 89.61% year-over-year to $108399.0; the trailing twelve-month figure through Jan 2026 stood at $108399.0 (changed N/A YoY), and the FY2025 full-year result was $108399.0, up 1138.85% from the prior year.
- Share-based Compensation for Q2 2025 stood at $108399.0, up from -$1.0 million in the prior quarter.
- The five-year high for Share-based Compensation was $2.7 million in Q3 2021, with the low at -$2.4 million in Q3 2023.
- Average Share-based Compensation over 5 years is $417462.1, with a median of $522207.5 recorded in 2021.
- Year-over-year, Share-based Compensation soared 357.64% in 2022 and plunged 815.96% in 2023.
- Tracing ODYY's Share-based Compensation over 5 years: stood at $533105.0 in 2021, then soared by 119.22% to $1.2 million in 2022, then tumbled by 99.85% to $1750.0 in 2023, then slumped by 59691.54% to -$1.0 million in 2024, then soared by 110.39% to $108399.0 in 2025.
- The last three Share-based Compensation figures came in at $108399.0 (Q2 2025), -$1.0 million (Q3 2024), and $1.0 million (Q2 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 317.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 87.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 94.00 Mn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 83.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 45.40 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 43.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 35.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 12.90 Mn |
| 10 | Odyssey Health | - | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 30, 2025 | 108,399.00 |
| Apr 30, 2025 | 108,399.00 |
| Jul 31, 2024 | -1.04 Mn |
| Jul 31, 2024 | -1.04 Mn |
| Apr 30, 2024 | 1.04 Mn |
| Apr 30, 2024 | 1.04 Mn |
| Jan 31, 2024 | 7,000.00 |
| Jan 31, 2024 | 7,000.00 |
| Oct 31, 2023 | 1,750.00 |
| Oct 31, 2023 | 1,750.00 |
| Jul 31, 2023 | -2.43 Mn |
| Jul 31, 2023 | -2.43 Mn |
| Apr 30, 2023 | 598,964.00 |
| Apr 30, 2023 | 598,964.00 |
| Jan 31, 2023 | 659,846.00 |
| Jan 31, 2023 | 659,846.00 |
| Oct 31, 2022 | 1.17 Mn |
| Oct 31, 2022 | 1.17 Mn |
| Jul 31, 2022 | -264,830.00 |
| Jul 31, 2022 | -264,830.00 |
| Apr 30, 2022 | 2.04 Mn |
| Apr 30, 2022 | 2.04 Mn |
| Jan 31, 2022 | 511,310.00 |
| Jan 31, 2022 | 511,310.00 |
| Oct 31, 2021 | 533,105.00 |
| Oct 31, 2021 | 533,105.00 |
| Jul 31, 2021 | 2.74 Mn |
| Jul 31, 2021 | 2.74 Mn |
| Apr 30, 2021 | 887,437.00 |
| Apr 30, 2021 | 887,437.00 |
| Jan 31, 2021 | 111,728.00 |
| Jan 31, 2021 | 111,728.00 |
| Oct 31, 2020 | 130,281.00 |
| Oct 31, 2020 | 130,281.00 |
| Jul 31, 2020 | 2.78 Mn |
| Jul 31, 2020 | 2.78 Mn |
| Apr 30, 2020 | -1.50 Mn |
| Apr 30, 2020 | -1.50 Mn |
| Jan 31, 2020 | 181,874.00 |
| Jan 31, 2020 | 181,874.00 |
| Oct 31, 2019 | 1.05 Mn |
| Oct 31, 2019 | 1.05 Mn |
| Jul 31, 2019 | 54,417.00 |
| Jul 31, 2019 | 54,417.00 |
| Jan 31, 2019 | 47,000.00 |
| Jan 31, 2019 | 47,000.00 |